回复：让 - 路易·坎波斯 - 费尔南德斯、劳伦斯·巴斯蒂安、娜塔莉·尼古拉耶夫等。重复进行21针扩展穿刺活检患者的前列腺癌检出率。《欧洲泌尿外科杂志》2009年；55卷：600 - 609页。 - Suppr | 超能文献

Re: Jean-Louis Campos-Fernandes, Laurence Bastien, Nathalie Nicolaiew, et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 2009;55:600-9.

作者信息

Bratt Ola

出版信息

Eur Urol. 2009 Jul;56(1):e6-7; author reply e8-9. doi: 10.1016/j.eururo.2009.03.083. Epub 2009 Apr 3.

DOI:10.1016/j.eururo.2009.03.083

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Jean-Louis Campos-Fernandes, Laurence Bastien, Nathalie Nicolaiew, et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 2009;55:600-9.

Eur Urol. 2009 Jul;56(1):e6-7; author reply e8-9. doi: 10.1016/j.eururo.2009.03.083. Epub 2009 Apr 3.

2

Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.

Eur Urol. 2009 Mar;55(3):607. doi: 10.1016/j.eururo.2008.06.044. Epub 2008 Jun 23.

3

Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.

Eur Urol. 2009 Mar;55(3):608. doi: 10.1016/j.eururo.2008.06.045. Epub 2008 Jun 23.

4

Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.

Eur Urol. 2009 Mar;55(3):609. doi: 10.1016/j.eururo.2008.06.046. Epub 2008 Jun 23.

5

Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.

Eur Urol. 2008 Aug;54(2):469-70; author reply 471. doi: 10.1016/j.eururo.2008.02.015. Epub 2008 Feb 20.

6

Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.

Eur Urol. 2009 Mar;55(3):600-6. doi: 10.1016/j.eururo.2008.06.043. Epub 2008 Jun 23.

7

Re: Anup Patel. Re: Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. Eur Urol. 2012;61:223-4.

Eur Urol. 2012 Jul;62(1):e12; author reply e13. doi: 10.1016/j.eururo.2012.03.047. Epub 2012 Mar 30.

8

Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen-deprivation therapy--It's all a matter of timing. Eur Urol 2008;53:869-71.

Eur Urol. 2009 Feb;55(2):e40-2; author reply e45-6. doi: 10.1016/j.eururo.2008.08.039. Epub 2008 Aug 24.

9

Re: The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 2008; 180: 544-547.

J Urol. 2009 May;181(5):2387-8. doi: 10.1016/j.juro.2009.01.060. Epub 2009 Mar 20.

10

Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.

Eur Urol. 2019 Mar;75(3):e61-e62. doi: 10.1016/j.eururo.2018.10.030. Epub 2018 Oct 26.